Hideaki Miyake

13.8k total citations
620 papers, 10.8k citations indexed

About

Hideaki Miyake is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Hideaki Miyake has authored 620 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 319 papers in Pulmonary and Respiratory Medicine, 195 papers in Surgery and 173 papers in Molecular Biology. Recurrent topics in Hideaki Miyake's work include Renal cell carcinoma treatment (139 papers), Bladder and Urothelial Cancer Treatments (134 papers) and Prostate Cancer Treatment and Research (115 papers). Hideaki Miyake is often cited by papers focused on Renal cell carcinoma treatment (139 papers), Bladder and Urothelial Cancer Treatments (134 papers) and Prostate Cancer Treatment and Research (115 papers). Hideaki Miyake collaborates with scholars based in Japan, Canada and United States. Hideaki Miyake's co-authors include Masato Fujisawa, Isao Hara, Martin Gleave, Sadao Kamidono, Soichi Arakawa, Hiroshi Eto, Mototsugu Muramaki, Kazuki Yamanaka, Atsushi Takenaka and Toshifumi Kurahashi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Hideaki Miyake

600 papers receiving 10.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Hideaki Miyake	4.7k	4.0k	3.2k	2.7k	2.1k	620	10.8k
Mototsugu Oya	4.5k 1.0×	3.8k 1.0×	3.2k 1.0×	3.4k 1.3×	1.9k 0.9×	622	11.2k
Norio Nonomura	3.6k 0.8×	4.6k 1.2×	2.4k 0.7×	2.3k 0.9×	1.8k 0.9×	598	11.4k
Leonard G. Gomella	6.7k 1.4×	3.4k 0.9×	2.5k 0.8×	2.6k 1.0×	2.5k 1.2×	385	12.7k
Ganesh V. Raj	5.8k 1.2×	4.0k 1.0×	2.2k 0.7×	3.2k 1.2×	1.8k 0.8×	195	11.5k
Gregory T. MacLennan	4.8k 1.0×	5.0k 1.3×	2.2k 0.7×	3.5k 1.3×	2.2k 1.0×	321	11.4k
Dan Theodorescu	3.1k 0.7×	7.5k 1.9×	3.6k 1.1×	3.8k 1.4×	2.8k 1.3×	335	14.6k
Robert C. Flanigan	5.8k 1.2×	3.0k 0.8×	1.7k 0.5×	2.1k 0.8×	1.7k 0.8×	246	9.0k
M. Scott Lucia	7.7k 1.7×	3.2k 0.8×	2.2k 0.7×	2.2k 0.8×	1.8k 0.9×	193	14.4k
Mitchell C. Benson	8.6k 1.9×	3.9k 1.0×	2.8k 0.9×	3.1k 1.2×	2.2k 1.0×	268	13.3k
David I. Quinn	4.8k 1.0×	4.0k 1.0×	5.8k 1.8×	4.5k 1.7×	2.3k 1.1×	420	14.1k

Countries citing papers authored by Hideaki Miyake

Since Specialization

Citations

This map shows the geographic impact of Hideaki Miyake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Miyake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Miyake more than expected).

Fields of papers citing papers by Hideaki Miyake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Miyake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Miyake. The network helps show where Hideaki Miyake may publish in the future.

Co-authorship network of co-authors of Hideaki Miyake

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Miyake. A scholar is included among the top collaborators of Hideaki Miyake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Miyake. Hideaki Miyake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fujimoto, Takuya, et al.. (2025). Impact of Fc-gamma receptor IIIA polymorphism on late-onset neutropenia and clinical outcomes in kidney transplant recipients following rituximab induction therapy. Clinical and Experimental Nephrology. 29(5). 681–689.

Hara, Takuto, et al.. (2025). Toward safe clinical deployment of remote robotic surgery in Japan: five-year validation of the hinotori™ system using 5G wireless communication. International Journal of Clinical Oncology. 30(12). 2389–2398.

Kawai, Taketo, Hideyasu Matsuyama, Keita Kobayashi, et al.. (2024). Photodynamic diagnosis‐assisted transurethral resection of bladder tumor for high‐risk non‐muscle invasive bladder cancer improves intravesical recurrence‐free survival (BRIGHT study). International Journal of Urology. 31(8). 906–912. 5 indexed citations

Watanabe, Kyohei, Atsushi Otsuka, Yuichi Kitagawa, et al.. (2024). Preoperative factors predicting poor therapeutic efficacy of holmium laser enucleation of the prostate in patients with benign prostatic hyperplasia. LUTS Lower Urinary Tract Symptoms. 16(4). e12530–e12530. 1 indexed citations

Motoyama, Daisuke, Yuto Matsushita, Hiromitsu Watanabe, et al.. (2023). Robot‐assisted adrenalectomy using a hinotori surgical robot system: Report of first series of six cases. Asian Journal of Endoscopic Surgery. 16(3). 489–495. 29 indexed citations

Sato, Ryo, et al.. (2023). Optimal Time Point for Evaluation of Response to Pembrolizumab Treatment in Japanese Patients With Metastatic Urothelial Carcinoma. Cancer Diagnosis & Prognosis. 3(3). 370–376.

Watanabe, Hiromitsu, Yuto Matsushita, Keita Tamura, et al.. (2023). Assessments of therapeutic effects according to timings for combined therapy with axitinib and immune check point inhibitor in a mouse renal cell carcinoma model. Scientific Reports. 13(1). 11361–11361. 5 indexed citations

Tomita, Yoshihiko, Robert J. Motzer, Toni K. Choueiri, et al.. (2023). Efficacy of avelumab plus axitinib versus sunitinib by numbers of IMDC risk factors and target tumor sites at baseline in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101. ESMO Open. 8(6). 102034–102034. 6 indexed citations

Kitajima, Kazuhiro, Junpei Kuyama, Takashi Kawahara, et al.. (2023). Assessing Therapeutic Response to Radium-223 with an Automated Bone Scan Index among Metastatic Castration-Resistant Prostate Cancer Patients: Data from Patients in the J-RAP-BSI Trial. Cancers. 15(10). 2784–2784. 7 indexed citations

10.

Miyake, Hideaki, Yasumasa Kakei, Yuzo Nakano, et al.. (2023). Efficacy and safety of apalutamide in patients with metastatic castration-resistant prostate cancer (GENESIS): protocol for a multicentre, open-label, single-arm clinical trial. BMJ Open. 13(3). e070173–e070173. 1 indexed citations

11.

Nishiyama, Hiroyuki, Junji Yonese, Takashi Kawahara, et al.. (2023). TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma. Molecular Cancer Therapeutics. 23(4). 532–540. 1 indexed citations

12.

Nakane, Keita, Hiromitsu Watanabe, Taku Naiki, et al.. (2023). Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence. Diagnostics. 13(9). 1661–1661. 5 indexed citations

13.

Naiki, Taku, Kiyoshi Takahara, Hiromitsu Watanabe, et al.. (2023). The Geriatric Nutritional Risk Index Predicts Prognosis in Japanese Patients with LATITUDE High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Multi-Center Study. Cancers. 15(22). 5333–5333. 4 indexed citations

14.

Nishimura, Nobutaka, Makito Miyake, Tatsuki Miyamoto, et al.. (2023). Impact on Japanese healthcare economics of photodynamic diagnosis‐assisted transurethral resection of bladder tumor for non‐muscle invasive bladder cancer: A multicenter retrospective cohort study. International Journal of Urology. 30(12). 1112–1119. 2 indexed citations

15.

Uemura, Hirotsugu, Atsushi Mizokami, Hideaki Miyake, et al.. (2022). Treatment strategies and outcomes in a long‐term registry study of patients with high‐risk metastatic hormone‐naïve prostate cancer in Japan: An interim analysis of the J‐ROCK study. International Journal of Urology. 29(9). 1061–1070. 10 indexed citations

16.

Kitajima, Kazuhiro, Hiroyuki Yokoyama, Masayuki Fujiwara, et al.. (2022). Evaluation of ¹¹C‐choline positron emission tomography/computed tomography for determining treatment response in castration‐resistant prostate cancer patients. International Journal of Urology. 29(9). 1072–1078. 3 indexed citations

17.

Takahara, Kiyoshi, Taku Naiki, Toshiki Ito, et al.. (2021). Useful predictors of progression‐free survival for Japanese patients with LATITUDE‐high‐risk metastatic castration‐sensitive prostate cancer who received upfront abiraterone acetate. International Journal of Urology. 29(3). 229–234. 7 indexed citations

18.

Tanaka, Kazushi, Katsumi Shigemura, Mototsugu Muramaki, et al.. (2013). Efficacy of Using Three-Tesla Magnetic Resonance Imaging Diagnosis of Capsule Invasion for Decision-Making About Neurovascular Bundle Preservation in Robotic-Assisted Radical Prostatectomy. Korean journal of urology. 54(7). 437–437. 17 indexed citations

19.

Miyake, Hideaki, et al.. (1999). Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to disease progression and recurrence. Cancer. 86(2). 316–324. 5 indexed citations

20.

Miyake, Hideaki, Isao Hara, Kazuki Yamanaka, et al.. (1999). Increased angiogenin expression in the tumor tissue and serum of urothelial carcinoma patients is related to disease progression and recurrence. Cancer. 86(2). 316–324. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact